Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Judson

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|October 1, 1994
A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanomaN M Bleehen, A H Calvert, S M Lee, et al.
British Journal of Cancer|April 1, 1995
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancersF J Cowie, C R Pinkerton, M Phillips, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
European Journal of Cancer Care|April 30, 2015
Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyL Jönsson, N Justo, A Musayev, et al.
British Journal of Cancer|January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesT Hickish, P Serafinowski, D Cunningham, et al.
British Journal of Cancer|August 22, 2013
Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumoursV R Bulusu, J Fullarton, M Leahy, et al.
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1990
How many tests are required in the diagnosis of palpable breast abnormalities?J R Hardy, T J Powles, I Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapyJ-Y Blay, M van Glabbeke, J Verweij, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|October 1, 1994
A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanomaN M Bleehen, A H Calvert, S M Lee, et al.
British Journal of Cancer|April 1, 1995
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancersF J Cowie, C R Pinkerton, M Phillips, et al.
British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.
European Journal of Cancer Care|April 30, 2015
Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyL Jönsson, N Justo, A Musayev, et al.
British Journal of Cancer|January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesT Hickish, P Serafinowski, D Cunningham, et al.
British Journal of Cancer|August 22, 2013
Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumoursV R Bulusu, J Fullarton, M Leahy, et al.
British Journal of Cancer|May 20, 2004
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancerA O'Donnell, I Judson, M Dowsett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J B Vermorken, M Clavel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1990
How many tests are required in the diagnosis of palpable breast abnormalities?J R Hardy, T J Powles, I Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapyJ-Y Blay, M van Glabbeke, J Verweij, et al.
Pageof 12